GFAP and Alzheimer disease: Compared to CU individuals, those who developed either MCI or AD were older; were more likely to be Hispanic; had more comorbidities (specifically, hypertension and arthritis); and had higher levels of p‐tau181, NfL, GFAP, and higher p‐tau181/Aβ42.